Familial Evaluation in Catecholaminergic Polymorphic Ventricular Tachycardia

Werf et al. (Wed,) studied this question.

www.synapsesocial.com/papers/69d573c85883a1e80be3bc34 — DOI: https://doi.org/10.1161/circep.112.970517

Also consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. Incidence and Risk Factors of Arrhythmic Events in Catecholaminergic Polymorphic Ventricular Tachycardia· 2009 · 555 citations
2. Arrhythmia characterization and long-term outcomes in catecholaminergic polymorphic ventricular tachycardia· 2011 · 197 citations
3. Flecainide Therapy Reduces Exercise-Induced Ventricular Arrhythmias in Patients With Catecholaminergic Polymorphic Ventricular Tachycardia· 2011 · 399 citations
4. High prevalence of exercise-induced arrhythmias in catecholaminergic polymorphic ventricular tachycardia mutation-positive family members diagnosed by cascade genetic screening· 2010 · 73 citations
5. Catecholaminergic polymorphic ventricular tachycardia: RYR2 mutations, bradycardia, and follow up of the patients· 2005 · 301 citations